Wulff H - Search Results

1

Editorial: Venoms, animal and microbial toxins, volume II.

Cao Z, Shahbazzadeh D, Kovacic H, McNutt PM, Wang JL, Wulff H, Utkin Y, Sabatier JM. Cao Z, et al. Among authors: wulff h. Front Pharmacol. 2022 Aug 19;13:973628. doi: 10.3389/fphar.2022.973628. eCollection 2022. Front Pharmacol. 2022. PMID: 36059944 Free PMC article. No abstract available.

2

The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.

Mouhat S, Mosbah A, Visan V, Wulff H, Delepierre M, Darbon H, Grissmer S, De Waard M, Sabatier JM. Mouhat S, et al. Among authors: wulff h. Biochem J. 2004 Jan 1;377(Pt 1):25-36. doi: 10.1042/BJ20030115. Biochem J. 2004. PMID: 12962541 Free PMC article.

3

K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom.

Mouhat S, Visan V, Ananthakrishnan S, Wulff H, Andreotti N, Grissmer S, Darbon H, De Waard M, Sabatier JM. Mouhat S, et al. Among authors: wulff h. Biochem J. 2005 Jan 1;385(Pt 1):95-104. doi: 10.1042/BJ20041379. Biochem J. 2005. PMID: 15588251 Free PMC article.

4

Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain.

Mouhat S, Teodorescu G, Homerick D, Visan V, Wulff H, Wu Y, Grissmer S, Darbon H, De Waard M, Sabatier JM. Mouhat S, et al. Among authors: wulff h. Mol Pharmacol. 2006 Jan;69(1):354-62. doi: 10.1124/mol.105.017210. Epub 2005 Oct 18. Mol Pharmacol. 2006. PMID: 16234482

5

Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.

Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V. Wulff H, et al. Curr Med Chem. 2007;14(13):1437-57. doi: 10.2174/092986707780831186. Curr Med Chem. 2007. PMID: 17584055 Review.

6

Triarylmethanes, a new class of cx50 inhibitors.

Bodendiek SB, Rubinos C, Trelles MP, Coleman N, Jenkins DP, Wulff H, Srinivas M. Bodendiek SB, et al. Among authors: wulff h. Front Pharmacol. 2012 Jun 6;3:106. doi: 10.3389/fphar.2012.00106. eCollection 2012. Front Pharmacol. 2012. PMID: 22685432 Free PMC article.

7

The Trials and Tribulations of Structure Assisted Design of K_Ca Channel Activators.

Shim H, Brown BM, Singh L, Singh V, Fettinger JC, Yarov-Yarovoy V, Wulff H. Shim H, et al. Among authors: wulff h. Front Pharmacol. 2019 Sep 20;10:972. doi: 10.3389/fphar.2019.00972. eCollection 2019. Front Pharmacol. 2019. PMID: 31616290 Free PMC article.

8

Editorial: Venoms, Animal and Microbial Toxins.

Cao Z, Wang JL, McNutt PM, Utkin YN, Shahbazzadeh D, Wulff H, Kovacic H, Sabatier JM. Cao Z, et al. Among authors: wulff h. Front Pharmacol. 2021 May 26;12:706573. doi: 10.3389/fphar.2021.706573. eCollection 2021. Front Pharmacol. 2021. PMID: 34122121 Free PMC article. No abstract available.

9

Apamin structure and pharmacology revisited.

Kuzmenkov AI, Peigneur S, Nasburg JA, Mineev KS, Nikolaev MV, Pinheiro-Junior EL, Arseniev AS, Wulff H, Tytgat J, Vassilevski AA. Kuzmenkov AI, et al. Among authors: wulff h. Front Pharmacol. 2022 Sep 16;13:977440. doi: 10.3389/fphar.2022.977440. eCollection 2022. Front Pharmacol. 2022. PMID: 36188602 Free PMC article.

10

Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K+ channel, SkCa2.

Shakkottai VG, Regaya I, Wulff H, Fajloun Z, Tomita H, Fathallah M, Cahalan MD, Gargus JJ, Sabatier JM, Chandy KG. Shakkottai VG, et al. Among authors: wulff h. J Biol Chem. 2001 Nov 16;276(46):43145-51. doi: 10.1074/jbc.M106981200. Epub 2001 Aug 29. J Biol Chem. 2001. PMID: 11527975 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

497 results

Search Page